Fundraising FoxKoligo Therapeutics
Louisville, US · Founded 2016 · Kentucky corporation
Find your way into Koligo Therapeutics
Sign up to see every warm intro you have to Koligo Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Koligo Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MB
Matthew B LehmanNamed on SEC filing
BA
Balamurugan AppakalaiNamed on SEC filing
SW
Stuart WilliamsNamed on SEC filing
MH
Michael HughesNamed on SEC filing
DB
David BlanfordNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3.7M disclosed across 3 rounds · 2017–2020
▶$1.6MraisedOct 2020 · 2 investors · BiotechnologyRule 506(b)
▶$1.6MraisedOct 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew LehmanExecutive Officer
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- Minimum investment
- $20K
- First sale
- Sep 2020
- Incorporated
- Corporation, Kentucky
- Federal exemptions
- 06b
▶$2MraisedMar 2018 · 1 investors · BiotechnologyRule 506(b)
▶$2MraisedMar 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael HughesExecutive Officer, Director
- Stuart WilliamsExecutive Officer, Director
- Matthew B LehmanExecutive Officer, Director
- Balamurugan AppakalaiExecutive Officer, Director
- David BlanfordExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $2M
- Proceeds to insiders
- $100K
- First sale
- Mar 2018
- Incorporated
- Corporation, Kentucky, 2016
- Federal exemptions
- 06b
▶$5KraisedDec 2017 · 6 investors · BiotechnologyRule 506(b)
▶$5KraisedDec 2017 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew B LehmanExecutive Officer, Director
- Balamurugan AppakalaiDirector
- Stuart WilliamsDirector
- Michael HughesDirector
- David BlanfordDirector
- Offering amount
- $5K
- Amount sold
- $5K
- Proceeds to insiders
- $1K
- First sale
- Dec 2017
- Incorporated
- Corporation, Kentucky, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Koligo Therapeutics raised?
- Koligo Therapeutics has disclosed $3.7M raised across 3 rounds.
- Where is Koligo Therapeutics headquartered?
- Koligo Therapeutics is headquartered in Louisville, US.